N Acetylaspartic Acid

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 201 Experts worldwide ranked by ideXlab platform

Carolina Didonet Pederzolli - One of the best experts on this subject based on the ideXlab platform.

  • Neuroprotective role of lipoic Acid agaiNst acute toxicity of N-Acetylaspartic Acid
    Molecular and Cellular Biochemistry, 2010
    Co-Authors: Carolina Didonet Pederzolli, Andrea Pereira Rosa, Amanda Szekir Oliveira, Juliana G. Coelho, Débora Luz Becker, Giovana Reche Dalazen, Tarsila Barros Moraes, Carlos Severo Dutra-filho
    Abstract:

    N -Acetylaspartic Acid (NAA) accumulates iN CaNavaN disease, a severe iNherited Neurometabolic disorder cliNically characterized by meNtal retardatioN, hypotoNia, macrocephaly, aNd seizures. The mechaNisms of braiN damage iN this disease remaiN poorly uNderstood. ReceNt studies developed by our research group showed that NAA iNduces oxidative stress iN vitro aNd iN vivo iN cerebral cortex of rats. Lipoic Acid is coNsidered as aN efficieNt aNtioxidaNt which caN easily cross the blood–braiN barrier. CoNsideriNg the abseNce of specific treatmeNt to CaNavaN disease, this study evaluates the possible preveNtioN of the oxidative stress promoted by NAA iN vivo by the aNtioxidaNt lipoic Acid to prelimiNarily evaluate lipoic Acid efficacy agaiNst pro-oxidative effects of NAA. FourteeN-day-old Wistar rats received aN acute admiNistratioN of 0.6 mmol NAA/g body weight with or without lipoic Acid (40 mg/kg body weight). Catalase (CAT), glutathioNe peroxidase (GPx), aNd glucose 6-phosphate dehydrogeNase activities, hydrogeN peroxide coNteNt, thiobarbituric Acid-reactive substaNces (TBA-RS), spoNtaNeous chemilumiNesceNce, proteiN carboNyl coNteNt, total aNtioxidaNt poteNtial, aNd DNA–proteiN cross-liNks were assayed iN the cerebral cortex of rats. CAT, GPx activities, aNd total aNtioxidaNt poteNtial were sigNificaNtly reduced, while hydrogeN peroxide coNteNt, TBA-RS, spoNtaNeous chemilumiNesceNce, aNd proteiN carboNyl coNteNt were sigNificaNtly eNhaNced by acute admiNistratioN of NAA. Those effects were all preveNted by lipoic Acid pretreatmeNt. Our results clearly show that lipoic Acid may protect agaiNst the oxidative stress promoted by NAA. This could represeNt a New therapeutic approach to the patieNts affected by CaNavaN disease.

  • N-Acetylaspartic Acid impairs eNzymatic aNtioxidaNt defeNses aNd eNhaNces hydrogeN peroxide coNceNtratioN iN rat braiN
    Metabolic Brain Disease, 2010
    Co-Authors: Carolina Didonet Pederzolli, Caroline Paula Mescka, Ângela M. Sgaravatti, Mirian Bonaldi Sgarbi, Angela T. S. Wyse, Clovis Milton Duval Wannmacher, Alessandra Selinger Magnusson, Kátia Bueno Deckmann, Evelise Souza Streck, Moacir Wajner
    Abstract:

    N-Acetylaspartic Acid accumulates iN CaNavaN Disease, a severe iNherited Neurometabolic disease cliNically characterized by severe meNtal retardatioN, hypotoNia, macrocephaly aNd geNeralized toNic aNd cloNic type seizures. CoNsideriNg that the mechaNisms of braiN damage iN this disease remaiN poorly uNderstood, iN the preseNt study we iNvestigated the iN vitro aNd iN vivo effects of N-Acetylaspartic Acid oN the activities of catalase, superoxide dismutase aNd glutathioNe peroxidase, as well as oN hydrogeN peroxide coNceNtratioN iN cerebral cortex of 14-day-old rats. Catalase aNd glutathioNe peroxidase activities were sigNificaNtly iNhibited, while hydrogeN peroxide coNceNtratioN was sigNificaNtly eNhaNced by N-Acetylaspartic Acid both iN vitro aNd iN vivo. IN coNtrast, superoxide dismutase activity was Not altered by N-Acetylaspartic Acid. Our results clearly show that N-Acetylaspartic Acid impairs the eNzymatic aNtioxidaNt defeNses iN rat braiN. This could be iNvolved iN the pathophysiological mechaNisms respoNsible for the braiN damage observed iN patieNts affected by CaNavaN Disease.

  • INtracerebroveNtricular admiNistratioN of N-Acetylaspartic Acid impairs aNtioxidaNt defeNses aNd promotes proteiN oxidatioN iN cerebral cortex of rats
    Metabolic Brain Disease, 2009
    Co-Authors: Carolina Didonet Pederzolli, Francieli J. Rockenbach, Ângela M. Sgaravatti, Angela T. S. Wyse, Clovis Milton Duval Wannmacher, Moacir Wajner, Fernanda Rech Zanin, Nicoli Taiana Henn, Eline Coan Romagna, Ângela Mattos Dutra
    Abstract:

    N-Acetylaspartic Acid (NAA) is the biochemical hallmark of CaNavaN Disease, aN iNherited metabolic disease caused by deficieNcy of aspartoacylase activity. NAA is aN immediate precursor for the eNzyme-mediated biosyNthesis of N-acetylaspartylglutamic Acid (NAAG), whose coNceNtratioN is also iNcreased iN uriNe aNd cerebrospiNal fluid of patieNts affected by CD. This NeurodegeNerative disorder is cliNically characterized by severe meNtal retardatioN, hypotoNia aNd macrocephaly, aNd geNeralized toNic aNd cloNic type seizures. CoNsideriNg that the mechaNisms of braiN damage iN this disease remaiN Not fully uNderstood, iN the preseNt study we iNvestigated whether iNtracerebroveNtricular admiNistratioN of NAA or NAAG elicits oxidative stress iN cerebral cortex of 30-day-old rats. NAA sigNificaNtly reduced total radical-trappiNg aNtioxidaNt poteNtial, catalase aNd glucose 6-phosphate dehydrogeNase activities, whereas proteiN carboNyl coNteNt aNd superoxide dismutase activity were sigNificaNtly eNhaNced. Lipid peroxidatioN iNdices aNd glutathioNe peroxidase activity were Not affected by NAA. IN coNtrast, NAAG did Not alter aNy of the oxidative stress parameters tested. Our results iNdicate that iNtracerebroveNtricular admiNistratioN of NAA impairs aNtioxidaNt defeNses aNd iNduces oxidative damage to proteiNs, which could be iNvolved iN the Neurotoxicity of NAA accumulatioN iN CD patieNts.

  • N-Acetylaspartic Acid promotes oxidative stress iN cerebral cortex of rats.
    International Journal of Developmental Neuroscience, 2007
    Co-Authors: Carolina Didonet Pederzolli, Caroline Paula Mescka, Fernanda Scapin, Francieli J. Rockenbach, Ângela M. Sgaravatti, Mirian Bonaldi Sgarbi, Angela T. S. Wyse, Clovis Milton Duval Wannmacher, Moacir Wajner, Carlos Severo Dutra-filho
    Abstract:

    Abstract N -Acetylaspartic Acid accumulates iN CaNavaN Disease, a severe leukodystrophy characterized by swelliNg aNd spoNgy degeNeratioN of the white matter of the braiN. This iNherited metabolic disease, caused by deficieNcy of the eNzyme aspartoacylase, is cliNically characterized by severe meNtal retardatioN, hypotoNia aNd macrocephaly, aNd also geNeralized toNic aNd cloNic type seizures iN about half of the patieNts. CoNsideriNg that the mechaNisms of braiN damage iN this disease remaiN Not fully uNderstood, iN the preseNt study we iNvestigated whether oxidative stress is elicited by N -Acetylaspartic Acid. The iN vitro effect of N -Acetylaspartic Acid (10–80 mM) was studied oN oxidative stress parameters: total radical-trappiNg aNtioxidaNt poteNtial (TRAP), total aNtioxidaNt reactivity (TAR), chemilumiNesceNce, thiobarbituric Acid-reactive substaNces (TBA-RS), reduced glutathioNe coNteNt, sufhydryl coNteNt aNd carboNyl coNteNt iN the cerebral cortex of 14-day-old rats. The effect of the acute admiNistratioN of N -Acetylaspartic Acid (0.1–0.6 mmol/g body weight) was studied oN TRAP, TAR, carboNyl coNteNt, chemilumiNesceNce aNd TBA-RS. TRAP, TAR, reduced glutathioNe coNteNt aNd sulfhydryl coNteNt were sigNificaNtly reduced, while chemilumiNesceNce, TBA-RS aNd carboNyl coNteNt were sigNificaNtly eNhaNced by N -Acetylaspartic Acid iN vitro . The eNhaNcemeNt iN TBA-RS promoted by N -Acetylaspartic Acid was completely preveNted by ascorbic Acid plus Trolox, aNd partially preveNted by glutathioNe aNd dithiothreitol. The acute admiNistratioN of N -Acetylaspartic Acid also sigNificaNtly reduced TRAP aNd TAR, aNd sigNificaNtly eNhaNced carboNyl coNteNt, chemilumiNesceNce aNd TBA-RS. Our results iNdicate that N -Acetylaspartic Acid promotes oxidative stress by stimulatiNg lipid peroxidatioN, proteiN oxidatioN aNd by decreasiNg NoN-eNzymatic aNtioxidaNt defeNses iN rat braiN. This could be aNother pathophysiological mechaNism iNvolved iN CaNavaN Disease.

Osama Y Aldirbashi - One of the best experts on this subject based on the ideXlab platform.

  • reliable preNatal diagNosis of caNavaN disease by measuriNg N acetylaspartate iN amNiotic fluid usiNg liquid chromatography taNdem mass spectrometry
    Prenatal Diagnosis, 2009
    Co-Authors: Osama Y Aldirbashi, Wesam Kurdi, Faiqa Imtiaz, Asmahan M Ahmad, Moeenaldeen Alsayed, Maha Tulbah, Maha Alnemer, Mohamed S Rashed
    Abstract:

    Objective PreNatal diagNosis of CaNavaN disease by measuriNg N-Acetylaspartic Acid (NAA) iN amNiotic fluid is reliable aNd preferred over aspartoacylase eNzyme assay especially iN populatioNs with uNkNowN mutatioNs. Typically based oN GC–MS, existiNg methods are time-coNsumiNg aNd laborious. We developed a Novel LC–MS/MS method for determiNatioN of NAA iN amNiotic fluid with miNimal sample preparatioN. Method NAA aNd d3-NAA were detected by Negative-ioN electrospray ioNizatioN-MS/MS. QuaNtificatioN was achieved by staNdard additioN usiNg six 0.1 mL portioNs of each specimeN eNriched with iNcreasiNg NAA amouNts (0, 0.05, 0.1, 0.2, 0.3, aNd 0.4 µg) aNd eNdogeNous NAA was calculated by extrapolatioN. Results INjectioN-to-iNjectioN time was 2 miN whereas the turN arouNd time from sample receipt was about 1 h. INtraday (N = 10) aNd iNterday (N = 10) variatioNs were less thaN 9.4%. The refereNce raNge determiNed usiNg gestatioN-matched coNtrols (N = 12) of 1.1–2.7 µmol/L is iN agreemeNt with the literature. SpecimeNs from at-risk pregNaNcies with established diagNosis (N = 4) were successfully aNalyzed. CoNclusioN We developed a New method that eNables reliable, seNsitive, aNd selective determiNatioN of NAA iN a small volume of amNiotic fluid for the preNatal diagNosis of CaNavaN disease. The simple sample preparatioN adopted iN this work precluded the Necessity for extractioN aNd derivatizatioN. Copyright © 2009 JohN Wiley & SoNs, Ltd.

  • stable isotope dilutioN aNalysis of N Acetylaspartic Acid iN uriNe by liquid chromatography electrospray ioNizatioN taNdem mass spectrometry
    Biomedical Chromatography, 2007
    Co-Authors: Osama Y Aldirbashi, Mohamed S Rashed, Manhal Almokhadab, Khalid Alqahtani, Moeen A A Alsayed, Wesam Kurdi
    Abstract:

    N-Acetylaspartic Acid (NAA) is a specific uriNary marker for CaNavaN disease, aN autosomal recessive leukodystrophy. We developed a 'dilute aNd shoot' stable isotope dilutioN liquid chromatography taNdem mass spectrometry (LC-MS/MS) method for determiNatioN of NAA iN uriNe. Deuterated iNterNal staNdard d(3)-NAA was added to uNtreated uriNe aNd the mixture was iNjected iNto the LC-MS/MS system operated iN the Negative ioN mode. Chromatography was carried out oN a C(8) miNibore columN usiNg 50% acetoNitrile solutioN coNtaiNiNg 0.05% formic Acid at a flow rate of 0.25 mL/miN. The reteNtioN time was 1.6 miN aNd the turNarouNd time was 2.2 miN. NAA aNd d(3)-NAA were aNalyzed iN multiple reactioN moNitoriNg mode. Calibrators aNd quality coNtrol samples were prepared iN pooled coNtrol uriNe. The assay was liNear up to 2000 micromol/L with limit of quaNtificatioN at 1 micromol/L (S/N = 12). INterassay aNd iNtraassay coefficieNts of variatioN were less thaN 7% aNd recovery at three differeNt coNceNtratioNs was 98.9-102.5%. The LC-MS/MS method for NAA as described iNvolves No extractioN aNd No derivatizatioN, showed No iNterfereNce aNd gave excelleNt recovery with low variability aNd short aNalytical time. The method was successfully applied for the retrospective aNalysis of uriNe from 21 CaNavaN disease cases.

  • quaNtificatioN of N Acetylaspartic Acid iN uriNe by lc ms ms for the diagNosis of caNavaN disease
    Journal of Inherited Metabolic Disease, 2007
    Co-Authors: Osama Y Aldirbashi, Mohamed S Rashed, Manhal Almokhadab, Khalid Alqahtani, Wesam Kurdi, Moeen A A Alsayed
    Abstract:

    CaNavaN disease is aN autosomal recessive leukodystrophy characterized by excessive excretioN of N-Acetylaspartic Acid (NAA) iN uriNe. The disease is caused by deficieNcy of aspartoacylase, the eNzyme respoNsible for the hydrolysis of NAA iNto acetate aNd l-aspartate. PatieNts, who are ofteN asymptomatic iN their early moNths, show a wide spectrum of cliNical preseNtatioN thereafter that iNcludes macrocephaly, poor head coNtrol, seizures, abNormal muscle toNe, optic atrophy, sigNificaNt developmeNtal delay aNd death. IN this work, we describe a simple liquid chromatography–taNdem mass spectrometry (LC-MS/MS) method for the determiNatioN of NAA iN uriNe. The iNterNal staNdard d3-NAA was added to uNtreated uriNe aNd the mixture was iNjected iNto the LC-MS/MS system operated iN the Negative ioN mode. DetectioN was achieved iN multiple reactioN moNitoriNg (MRM) mode by moNitoriNg m/z 174 → 88, 174 → 130 aNd 174 → 58 for NAA aNd 177 → 89 for the iNterNal staNdard. SeparatioN was carried out oN a C8 columN (2.1 × 150 mm) usiNg a mixture of acetoNitrile aNd water (1:1 v/v) coNtaiNiNg 0.05% formic Acid at a flow rate of 0.25 ml/miN. NAA was eluted at 1.6 miN aNd the ruN time was approximately 2 miN. UsiNg spiked uriNe, the assay was liNear up to 2 mmol/L with limit of quaNtificatioN at 1 μmol/L (S/N = 12). NAA iN patieNts’ uriNe (N = 17) raNged betweeN 366 aNd 21235 mmol/mol creatiNiNe compared to coNtrols of <39 mmol/mol creatiNiNe (N = 159). This LC-MS/MS method for NAA as described iNvolved No extractioN aNd No derivatizatioN, showed No iNterfereNce, aNd gave excelleNt recovery with low variability aNd short aNalytical time.

Mohamed S Rashed - One of the best experts on this subject based on the ideXlab platform.

  • reliable preNatal diagNosis of caNavaN disease by measuriNg N acetylaspartate iN amNiotic fluid usiNg liquid chromatography taNdem mass spectrometry
    Prenatal Diagnosis, 2009
    Co-Authors: Osama Y Aldirbashi, Wesam Kurdi, Faiqa Imtiaz, Asmahan M Ahmad, Moeenaldeen Alsayed, Maha Tulbah, Maha Alnemer, Mohamed S Rashed
    Abstract:

    Objective PreNatal diagNosis of CaNavaN disease by measuriNg N-Acetylaspartic Acid (NAA) iN amNiotic fluid is reliable aNd preferred over aspartoacylase eNzyme assay especially iN populatioNs with uNkNowN mutatioNs. Typically based oN GC–MS, existiNg methods are time-coNsumiNg aNd laborious. We developed a Novel LC–MS/MS method for determiNatioN of NAA iN amNiotic fluid with miNimal sample preparatioN. Method NAA aNd d3-NAA were detected by Negative-ioN electrospray ioNizatioN-MS/MS. QuaNtificatioN was achieved by staNdard additioN usiNg six 0.1 mL portioNs of each specimeN eNriched with iNcreasiNg NAA amouNts (0, 0.05, 0.1, 0.2, 0.3, aNd 0.4 µg) aNd eNdogeNous NAA was calculated by extrapolatioN. Results INjectioN-to-iNjectioN time was 2 miN whereas the turN arouNd time from sample receipt was about 1 h. INtraday (N = 10) aNd iNterday (N = 10) variatioNs were less thaN 9.4%. The refereNce raNge determiNed usiNg gestatioN-matched coNtrols (N = 12) of 1.1–2.7 µmol/L is iN agreemeNt with the literature. SpecimeNs from at-risk pregNaNcies with established diagNosis (N = 4) were successfully aNalyzed. CoNclusioN We developed a New method that eNables reliable, seNsitive, aNd selective determiNatioN of NAA iN a small volume of amNiotic fluid for the preNatal diagNosis of CaNavaN disease. The simple sample preparatioN adopted iN this work precluded the Necessity for extractioN aNd derivatizatioN. Copyright © 2009 JohN Wiley & SoNs, Ltd.

  • stable isotope dilutioN aNalysis of N Acetylaspartic Acid iN uriNe by liquid chromatography electrospray ioNizatioN taNdem mass spectrometry
    Biomedical Chromatography, 2007
    Co-Authors: Osama Y Aldirbashi, Mohamed S Rashed, Manhal Almokhadab, Khalid Alqahtani, Moeen A A Alsayed, Wesam Kurdi
    Abstract:

    N-Acetylaspartic Acid (NAA) is a specific uriNary marker for CaNavaN disease, aN autosomal recessive leukodystrophy. We developed a 'dilute aNd shoot' stable isotope dilutioN liquid chromatography taNdem mass spectrometry (LC-MS/MS) method for determiNatioN of NAA iN uriNe. Deuterated iNterNal staNdard d(3)-NAA was added to uNtreated uriNe aNd the mixture was iNjected iNto the LC-MS/MS system operated iN the Negative ioN mode. Chromatography was carried out oN a C(8) miNibore columN usiNg 50% acetoNitrile solutioN coNtaiNiNg 0.05% formic Acid at a flow rate of 0.25 mL/miN. The reteNtioN time was 1.6 miN aNd the turNarouNd time was 2.2 miN. NAA aNd d(3)-NAA were aNalyzed iN multiple reactioN moNitoriNg mode. Calibrators aNd quality coNtrol samples were prepared iN pooled coNtrol uriNe. The assay was liNear up to 2000 micromol/L with limit of quaNtificatioN at 1 micromol/L (S/N = 12). INterassay aNd iNtraassay coefficieNts of variatioN were less thaN 7% aNd recovery at three differeNt coNceNtratioNs was 98.9-102.5%. The LC-MS/MS method for NAA as described iNvolves No extractioN aNd No derivatizatioN, showed No iNterfereNce aNd gave excelleNt recovery with low variability aNd short aNalytical time. The method was successfully applied for the retrospective aNalysis of uriNe from 21 CaNavaN disease cases.

  • quaNtificatioN of N Acetylaspartic Acid iN uriNe by lc ms ms for the diagNosis of caNavaN disease
    Journal of Inherited Metabolic Disease, 2007
    Co-Authors: Osama Y Aldirbashi, Mohamed S Rashed, Manhal Almokhadab, Khalid Alqahtani, Wesam Kurdi, Moeen A A Alsayed
    Abstract:

    CaNavaN disease is aN autosomal recessive leukodystrophy characterized by excessive excretioN of N-Acetylaspartic Acid (NAA) iN uriNe. The disease is caused by deficieNcy of aspartoacylase, the eNzyme respoNsible for the hydrolysis of NAA iNto acetate aNd l-aspartate. PatieNts, who are ofteN asymptomatic iN their early moNths, show a wide spectrum of cliNical preseNtatioN thereafter that iNcludes macrocephaly, poor head coNtrol, seizures, abNormal muscle toNe, optic atrophy, sigNificaNt developmeNtal delay aNd death. IN this work, we describe a simple liquid chromatography–taNdem mass spectrometry (LC-MS/MS) method for the determiNatioN of NAA iN uriNe. The iNterNal staNdard d3-NAA was added to uNtreated uriNe aNd the mixture was iNjected iNto the LC-MS/MS system operated iN the Negative ioN mode. DetectioN was achieved iN multiple reactioN moNitoriNg (MRM) mode by moNitoriNg m/z 174 → 88, 174 → 130 aNd 174 → 58 for NAA aNd 177 → 89 for the iNterNal staNdard. SeparatioN was carried out oN a C8 columN (2.1 × 150 mm) usiNg a mixture of acetoNitrile aNd water (1:1 v/v) coNtaiNiNg 0.05% formic Acid at a flow rate of 0.25 ml/miN. NAA was eluted at 1.6 miN aNd the ruN time was approximately 2 miN. UsiNg spiked uriNe, the assay was liNear up to 2 mmol/L with limit of quaNtificatioN at 1 μmol/L (S/N = 12). NAA iN patieNts’ uriNe (N = 17) raNged betweeN 366 aNd 21235 mmol/mol creatiNiNe compared to coNtrols of <39 mmol/mol creatiNiNe (N = 159). This LC-MS/MS method for NAA as described iNvolved No extractioN aNd No derivatizatioN, showed No iNterfereNce, aNd gave excelleNt recovery with low variability aNd short aNalytical time.

Andrew Bivard - One of the best experts on this subject based on the ideXlab platform.

  • A compreheNsive aNalysis of metabolic chaNges iN the salvaged peNumbra
    Neuroradiology, 2016
    Co-Authors: Andrew Bivard, Nawaf Yassi, Venkatesh Krishnamurthy, Longting Lin, Christopher Levi, Neil J. Spratt, Ferdi Mittef, Stephen Davis, Mark Parsons
    Abstract:

    INtroductioN We aimed to assess metabolite profiles iN peri-iNfarct tissue with magNetic resoNaNce spectroscopy (MRS) aNd correlate these with early aNd late cliNical recovery. Methods ONe huNdred teN aNterior circulatioN ischemic stroke patieNts preseNtiNg to hospital withiN 4.5 h of symptom oNset aNd treated with iNtraveNous thrombolysis were studied. PatieNts uNderweNt computer tomography perfusioN (CTP) scaNNiNg aNd subsequeNtly 3-T magNetic resoNaNce imagiNg (MRI) 24 h after stroke oNset, iNcludiNg siNgle-voxel, short-echo-time (30 ms) MRS, aNd diffusioN- aNd perfusioN-weighted imagiNg (DWI aNd PWI). MRS voxels were placed iN the peri-iNfarct regioN iN reperfused peNumbral tissue. A coNtrol voxel was placed iN the coNtralateral homologous area. Results The coNceNtratioNs of total creatiNe (5.39 vs 5.85 mM, p  = 0.044) aNd N-Acetylaspartic Acid (NAA, 6.34 vs 7.13 mM ± 1.57, p  

  • AssociatioN betweeN baseliNe peri-iNfarct magNetic resoNaNce spectroscopy aNd regioNal white matter atrophy after stroke
    Neuroradiology, 2016
    Co-Authors: Nawaf Yassi, Bruce C.v. Campbell, Mark W. Parsons, Stephen M. Davis, Geoffrey A. Donnan, Bradford A. Moffat, Christopher Steward, Leonid Churilov, Patricia M. Desmond, Andrew Bivard
    Abstract:

    INtroductioN Cerebral atrophy after stroke is associated with poor fuNctioNal outcome. The predictioN aNd preveNtioN of post-stroke braiN atrophy could therefore represeNt a target for Neurorestorative therapies. We iNvestigated the associatioNs betweeN peri-iNfarct metabolite coNceNtratioNs measured by quaNtitative MRS aNd braiN volume chaNge iN the iNfarct hemisphere after stroke. Methods TweNty patieNts with ischemic stroke were eNrolled. PatieNts uNderweNt 3T-MRI withiN 1 week of oNset, aNd at 1 aNd 3 moNths. At the baseliNe scaN, aN MRS voxel was placed maNually iN the peri-iNfarct area aNd aNother iN the correspoNdiNg coNtralateral regioN. Volumetric aNalysis of T1 images was performed usiNg two automated processiNg packages. ChaNges iN gray aNd white matter volume were assessed as perceNtage chaNge betweeN 1 aNd 3 moNths. Results MeaN coNceNtratioNs (iNstitutioNal uNits) of N-Acetylaspartic Acid (NAA) (6.1 vs 7.0, p  = 0.039), total creatiNe (Cr+PCr) (5.4 vs 5.8, p  = 0.043), aNd iNositol (4.5 vs 5.0, p  = 0.014), were sigNificaNtly lower iN the peri-iNfarct regioN compared with the coNtralateral hemisphere. There was a sigNificaNt correlatioN betweeN baseliNe peri-iNfarct NAA aNd white matter volume chaNge iN the iNfarct hemisphere betweeN 1 aNd 3 moNths, with lower NAA beiNg associated with subsequeNt white matter atrophy (SpearmaN’s rho = 0.66, p  = 0.010). The baseliNe coNceNtratioN of Cr+PCr was also sigNificaNtly correlated with white matter atrophy iN the iNfarct hemisphere (SpearmaN’s rho = 0.59, p  = 0.027). Both of these associatioNs were sigNificaNt after adjustmeNt for the false discovery rate aNd were validated usiNg the secoNdary volumetric method. CoNclusioN MRS may be useful iN the predictioN of white matter atrophy post-stroke aNd iN the testiNg of Novel Neurorestorative therapies.

  • 32. : BaseliNe peri-iNfarct N-Acetylaspartic Acid coNceNtratioN correlates with subsequeNt white matter atrophy after ischaemic stroke
    Journal of Clinical Neuroscience, 2014
    Co-Authors: Nawaf Yassi, Bruce C.v. Campbell, Patricia Desmond, Mark W. Parsons, Stephen M. Davis, Andrew Bivard
    Abstract:

    LoNgitudiNal chaNges iN cerebral volume have beeN described iN ischaemic stroke aNd may correlate with loNg-term outcome. We tested the hypothesis that baseliNe peri-iNfarct coNceNtratioN of the NeuroNal metabolite N-Acetylaspartic Acid (NAA) correlates with subsequeNt cerebral volume chaNge after stroke. PatieNts with suprateNtorial ischaemic stroke uNderweNt 3 Tesla MRI withiN 1 week aNd at 1 aNd 3 moNths from oNset. Structural imagiNg iNvolved a T1-weighted axial magNetizatioN prepared rapid gradieNt echo (1 mm slices, repetitioN time 1.9 s, echo time 2.82 ms). NAA estimatioN was performed at baseliNe usiNg siNgle-voxel spectroscopy (3 × 3 × 3 cm voxels, echo time 30 ms) with the voxel placed iN the peri-iNfarct regioN determiNed by visual assessmeNt of the diffusioN-weighted image. QuaNtitative spectroscopic aNalysis was performed iN LCmodel. Cerebral volume chaNge was determiNed betweeN the 1 aNd 3 moNth scaNs due to the effects of oedema oN baseliNe scaNs. Grey aNd white matter volume, Normalised for head size, were determiNed usiNg SIENAX (part of FSL). The result was validated usiNg Freesurfer. FifteeN patieNts were iNcluded iN the aNalysis. MeaN age was 69 years (iNterwquartile raNge [IQR] 62–78). MediaN baseliNe NatioNal INstitutes of Health Stroke Scale score was 10 (IQR 5–14). MeaN peri-iNfarct NAA coNceNtratioN was 6.2 mM (IQR 5.1–7.6) versus 7.0 mM (IQR 6.0–8.0) iN the coNtralateral hemisphere (p

  • Abstract T P73: Peri INfarct N-Acetylaspartic Acid Predicts White Matter Atrophy After Ischemic Stroke
    Stroke, 2014
    Co-Authors: Nawaf Yassi, Bruce C.v. Campbell, Patricia Desmond, Mark W. Parsons, Andrew Bivard, Geoffrey A. Donnan, Stephen M. Davis
    Abstract:

    Objective: Cerebral volume chaNges post stroke have receNtly beeN described aNd may correlate with cliNical outcome. We aimed to determiNe whether peri iNfarct measuremeNt of the NeuroNal marker N-Acetylaspartic Acid (NAA) oN MagNetic ResoNaNce Spectroscopy (MRS) predicts progressive cerebral volume chaNge after stroke. Methods: 11 patieNts (7 male) with suprateNtorial ischemic stroke uNderweNt serial MRI withiN 1 week of oNset, aNd at 1 aNd 3 moNths. ImagiNg was performed oN a 3T SiemeNs Trio scaNNer. Structural imagiNg utilized a T1-weighted axial MPRAGE acquisitioN (1mm slices, TR1.9sec, TE2.82msec). NAA estimatioN was performed at the baseliNe scaN usiNg siNgle voxel MRS (TE30msec, 3x3x3cm voxels). The voxel was placed iN the peri iNfarct regioN as determiNed by assessmeNt of the diffusioN weighted image. QuaNtitative MRS aNalysis was performed usiNg LCmodel usiNg water refereNciNg. BraiN tissue volume, Normalized for subject head size, was estimated with SIENAX, part of FSL. Due to aNticipated effects of edema oN iNitial cerebral volume, chaNges iN grey, white aNd total braiN volume were assessed as perceNtage chaNge betweeN the 1 aNd 3 moNth scaNs. Results: MeaN age was 71yr (IQR 62-79yr). MediaN baseliNe NIHSS was 11 (IQR 6-14). MeaN baseliNe grey, white aNd total braiN volume were 713ml (IQR 683-749), 731mL (IQR 721-747) aNd 1444mL (IQR 1384-1503) respectively. There was a sigNificaNt correlatioN betweeN age aNd baseliNe grey matter volume (r2=0.73, p=0.001) aNd total braiN volume (r2=0.74, p=0.001). MeaN peri iNfarct NAA coNceNtratioN was 6.2mM (SD 1.3) compared with 7.0mM (SD 1.2) iN the coNtralateral hemisphere (p=0.09, paired t-test). MeaN perceNtage grey, white aNd total braiN volume chaNges were 1.2% (IQR -1.8-4.1), 0.4% (IQR -2.2-3.7) aNd 0.8% (IRQ -1.0-2.6) respectively. There was a sigNificaNt correlatioN betweeN baseliNe NAA iN the peri iNfarct regioN aNd chaNge iN white matter volume betweeN the 1 aNd 3 moNth time poiNts (r2=0.26, p=0.008). CoNclusioNs: EstimatioN of the NeuroNal marker NAA usiNg MRS may sigNify varyiNg degrees of NeuroNal damage after stroke which may correlate with the severity of axoNal degeNeratioN aNd subsequeNt white matter volume chaNges. Further validatioN aNd correlatioN with cliNical outcomes is required.

Sankar Surendran - One of the best experts on this subject based on the ideXlab platform.

  • N-Acetylaspartic Acid moNitors oxidative stress
    2011
    Co-Authors: Sankar Surendran
    Abstract:

    N-Acetylaspartic Acid (NAA) was discovered by TallaN et al., iN 1956. It is syNthesized from acetyl coeNzyme A aNd aspartate by a mitochoNdrial eNzyme, L-aspartate N-acetyltraNsferase (GoldsteiN, 1969). NAA is maiNly fouNd iN the gray matter of the braiN aNd also preseNt at lower levels iN the astroglia, white matter, superior cervical gaNglioN, spleNic Nerve, peripheral Nervous tissue of spleeN, luNg, liver, kidNey, muscle, ovary, thymus, stomach, heart, adreNal medulla aNd retiNa of fishes to mammals (see review, SureNdraN et al., 2011). Normal level of NAA is importaNt iN the maiNteNaNce of poteNtial aNtioxidaNts. N-Acetylaspartic Acid level is altered iN maNy diseases iNcludiNg alcoholic braiN (SchweiNsburg et al., 2001), braiN oedema (Demougeot et al., 2001), HIV-related demeNtia (Meyerhoff et al., 1993; Sacktor et al., 2005), HIV positive alcoholism (Pfefferbaum et al., 2005), CaNavaN disease (see review, SureNdraN et al., 2011), ParkiNsoN’s disease (SureNdraN aNd RajasaNkar, 2010), type 2 diabetes (SureNdraN et al., 2006) aNd spiNocerebellar ataxia type 1 (Oz et al., 2010). Altered levels of NAA chaNges Nitric oxide aNd poteNtial aNtioxidaNt levels to cause disease pathophysiology (SureNdraN, 2009; SureNdraN aNd RajasaNkar, 2010), suggestiNg NAA moNitors oxidative stress by regulatiNg aNtioxidaNt levels.

  • UpregulatioN of N-Acetylaspartic Acid iNduces oxidative stress to coNtribute iN disease pathophysiology.
    International Journal of Neuroscience, 2011
    Co-Authors: Sankar Surendran, Maheep Bhatnagar
    Abstract:

    N-Acetylaspartic Acid (NAA) is predomiNaNtly preseNt iN braiN aNd also preseNt iN lower amouNt iN peripheral orgaNs. The role of NAA iN pathophysiology is poorly uNderstood. Therefore the review was aimed to uNderstaNd coNtributioN of NAA iN disease process. AmNiotic fluid of mothers with CaNavaN disease (CD) fetus aNd patieNts with the disease show iNcreased levels of NAA. INcrease of this pathway is also reported iN ParkiNsoN's disease aNd type 2 diabetes. IN HIV-related demeNtia, NAA is affected. ReceNt studies suggest that upregulatioN of NAA leads to oxidative stress iNcludiNg upregulatioN of Nitric oxide aNd reduciNg poteNtial aNtioxidaNts. NAA also leads to physiological abNormalities iNcludiNg walkiNg disorder. These chaNges suggest that NAA coNtributes iN disease pathophysiology.

  • UpregulatioN of N-Acetylaspartic Acid resultiNg Nitric oxide toxicity iNduces aspartoacylase mutatioNs aNd proteiN iNteractioN to cause pathophysiology seeN iN CaNavaN disease.
    Medical Hypotheses, 2010
    Co-Authors: Sankar Surendran
    Abstract:

    Summary Aspartoacylase (ASPA) coNverts N-Acetylaspartic Acid iNto aspartate aNd acetate. IN CaNavaN disease (CD), N-Acetylaspartic Acid (NAA) is fouNd to be iNcreased aNd over 65 mutatioNs iNcludiNg IVS4+1 G→T, deletioN of iNtroNs aNd exoNs have beeN reported iN the ASPA geNe. These chaNges lead to severe form or mild form of CD. The preseNt study was aimed to uNderstaNd mechaNism iN the cause of mutatioNs iN ASPA aNd pathophysiology seeN iN patieNts with CD. We have reported that elevated levels of NAA iNduce iNducible Nitric oxide (iNOS) to produce Nitric oxide toxicity iN CD. Nitric oxide toxicity has beeN showN to iNduce several mutatioNs iNcludiNg base chaNge G→T aNd deletioN aNd eNhaNces proteiN iNteractioN iN several geNes. Therefore we hypothesize that upregulatioN of NAA stimulates NOS aNd the resultiNg Nitric oxide toxicity iNduces ASPA mutatioNs aNd proteiN iNteractioN to result pathophysiological abNormalities seeN iN patieNts with CD.

  • upregulatioN of N Acetylaspartic Acid alters iNflammatioN traNscriptioN aNd coNtractile associated proteiN levels iN the stomach aNd smooth muscle coNtractility
    Molecular Biology Reports, 2009
    Co-Authors: Sankar Surendran
    Abstract:

    N-Acetylaspartic Acid (NAA) is coNverted iNto aspartate aNd acetate by aspartoacylase. AbNormal levels of the eNzyme leads to accumulatioN of NAA aNd these chaNges have beeN observed iN CaNavaN disease aNd type 2 diabetes. How upregulatioN of NAA affect the gastroiNtestiNe proteiN levels aNd the fuNctioN is Not kNowN. INcubatioN of rat stomach tissue with NAA 1.5 mM, 1.5 μM aNd 1.5 NM iNduced iNflammatory ageNts TNFα, p38MAPK, iNOS, PKC, COX2 aNd ICAM3; traNscriptioN factors phospho-NF-kBp65, cjuN aNd cfos; coNtractile proteiNs MLCK aNd phospho MLC; aNd calcium chaNNel α1C aNd calcium chaNNel, voltage-depeNdeNt, beta 3 subuNit compared to their respective coNtrol. INcubatioN of circular smooth muscle cells with the above doses of NAA iNduced coNtractility compared to the coNtrol. These studies suggest that NAA alters proteiNs levels aNd smooth muscle coNtractility aNd these chaNges likely to coNtribute to gastroiNtestiNal disorder seeN iN these diseases.

  • upregulatioN of aspartoacylase activity iN the duodeNum of obesity iNduced diabetes mouse implicatioNs oN diabetic Neuropathy
    Biochemical and Biophysical Research Communications, 2006
    Co-Authors: Sankar Surendran, Reuben Matalon
    Abstract:

    Aspartoacylase (ASPA) hydrolyzes N-Acetylaspartic Acid (NAA) iNto aspartate aNd acetate. Normal hydrolysis of NAA is importaNt to maiNtaiN healthy NeuroNs. SiNce eNteric Neuropathy is oNe of the eveNts seeN iN diabetes, whether ASPA activity is affected iN diabetic coNditioN is Not kNowN. IN order to iNvestigate the possibility, ASPA activity was examiNed iN the duodeNum aNd braiN of obesity iNduced diabetes model mouse. Aspartoacylase activity was high iN the diabetic mouse duodeNum compared to coNtrol duodeNum. The same result was also observed by immuNostaiNiNg of the mouse duodeNum. The activity of ASPA was fouNd to be elevated iN the braiN of diabetic mouse compared to the coNtrol braiN. These data suggest that Normal hydrolysis of NAA is affected by ASPA activity seeN iN the type 2 diabetes model mouse aNd this chaNge is likely to coNtribute to Neuropathy seeN iN diabetes, if documeNted also iN patieNts with type 2 diabetes.